Tag Archives: NASDAQ

NeuroSense Therapeutics Ltd., (Nasdaq: NRSN) ("NeuroSense"), a clinical-stage biotechnology company focused on discovering and

(NASDAQ:DXCM) does use debt in its business. But the real question is whether this debt is making the company risky. Debt assists a business until the business has trouble paying it off, either with new capital or with free cash flow.

This post was contributed by a representative of Montgomery Investment Management Pty Limited (AFSL No. 354564). The principal purpose of this post is to provide factual information and not provide financial product advice.

There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try

Australian shares are set to open sharply higher, as global markets rebounded for a second straight day on views the Omicron COVID-19 variant will not cause major economic damage.

"We've been bargaining our contract for almost two years, but BuzzFeed won't budge on critical issues like wages — all while preparing to

It is hard to get excited after looking at IntriCon's (NASDAQ:IIN) recent performance, when its stock has declined 28% over the past three months. It is possible that the markets have ignored the company's differing financials and decided to lean-in to the negative sentiment.

The disappointing November jobs report added to the uncertainty as investors try to chart the path of Fed policy.

Rumble Inc. ("Rumble" or "the Company"), the neutral video platform, and CF Acquisition Corp. VI (Nasdaq: CFVI) ("CFVI"), a special

East Resources Acquisition Company (NASDAQ: ERES) (the "Company") today announced that, on November 30, 2021, it received a notice (the "Notice") from the Listing Qualifications Department of The NASDAQ Stock Market LLC ("NASDAQ") stating that the Company is not in compliance with NASDAQ Listing Rule 5250(c)(1) (the "Rule") because the …